Annual Report 2001 - The Hospital for Sick Children

Till C, Koren, G, J, Westall C, Rovet, J (2001).
Prenatal exposure to organic solvents and
child neurobehavioral performance.
Neurotoxicology and Teratology, 23, 235-
245.
Till C, Westall C, Rovet JF, Koren G. (2001).
Prenatal exposure to organic solvents and
color vision impairment. Teratology
64:134-141.
books and book chapters
Curtis J, Hamilton J, Beck C, Frank M,
Daneman D. Pediatric Diabetes. In: Evidence-
Based Diabetes Care, eds. Gerstein H, Haynes
B. BC Decker 2001, pages 107-123.
Daneman D, Frank M, Perlman K. When a
Child has Diabetes. Key Porter Books,
Toronto 2002 (2nd Edition).
Koren, G., Nulman, I., Rovet, J., Greenbaum,
R., Loebstein, M., Einarson, T.R. (2001) Longterm
neurodevelopmental risks in children
exposed in utero to cocoain. In. G. Koren
(Ed). Maternal-Fetal Toxicology, Third Edition.
New York: Marcel Dekker, pp. 447-456.
Rovet J (2002). Long term follow-up of
children born with sporadic congenital
hypothyroidism. A Deacde of Advances in
Thyroidology, 66-70.
Till, C, Rovet, J. F., Koren, G, Westall, C. A.
Assessment of visual functions following
prenatal exposure to organic solvents.
National Institute for Occupational Safety
and Prevention (ISPESL). 2002
research and investigations
A 24-week randomized, doubleblind,
active-controlled multicentre
study to evaluate the safety
and efficacy of rosiglitazone when
administered to pediatric patients
with type 2 diabetes mellitus.
Hamilton J: GlaxoSmithKline ($20,000 2001
- 2002).
A comparison of two family-based
interventions for girls with type 1
diabetes and problematic eating
attitudes and behaviours. Daneman D:
Canadian Diabetes Association ($75,000
2001 - 2003).
Efficacy and safety of somatropin
treatment in paediatric patients
with SHOX-Disorder and SHOX-
Deficient Turner Syndrome. Wherrett
DK: Eli Lilly Canada Inc. ($41,420 2001 -
2002).
Fetal Alcohol Syndrome: Oxidative
Stress and Innovative Therapies. Brien,
J, Rovet J: Canadian Institutes of Health
Research New Emerging Team Grant
($1,250,000 2002 – 2007)
Genentech National Cooperative
Growth Study (NCGS) post marketing
surveillance program for protropin
and nutropin. Hamilton J: Hospital for Sick
Children ($7,500 2001 - 2002).
GLUT4 activation in insulin action
and insulin resistance. Klip A: Canadian
Diabetes Association Grant-In-Aid
($150,000 2002-2004)
GLUT4 transgenic mice: a tool for
the development of unique antidiabetic
drug Strategies. Klip A.
Canadian Institutes for Health Research
Proof-of-Principle Grant ($93,000 2002-
2003)
Hormonal regulation of p38 MAPK
and its implications for glucose
transport. Klip A: Canadian Institutes of
Health Research Operating Grant
($663,610 2002-2007)
Hypoglycemia and brain function in
children with diabetes. Rovet J. -
Psychology Research, Hospital for Sick Children,
Co Investigator Perlman K: Banting and Best
Diabetes Centre ($19,500 2000 - 2001).
Hypothyroxinemia of Prematurity.
Rovet, J: March of Dimes ($129,150 (USD)
2001- 2004)
Is poor glycemic control in
adolescents with type 1 diabetes
amenable to pharmacotherapy? A
pilot study of the insulinsensitizing
agent, metformin.
Daneman D, Hamilton J, Cummings B, Sochett E:
Hospital for Sick Children - Research
Institute Seed Grant ($29,820 1998 -
2001).
Maternal occupational exposure to
organic solvents during pregnancy
and infant visual processing. Rovet J:
Workman’s Safety Insurance Board
($258,000 2001- 2003)
Psychosocial adjustment and
gender identity in genetic males
born with ambiguous genitalia.
Wherrett DK, Zucker K, Neilson B, Bradley S: The
Hospital for Sick Children, Research
Institute ($31,180 2001 - 2003).
School attendance in children with
type 1 diabetes. Daneman D: Eli Lilly
Canada (unrestricted grant) ($26,000
2001).
Spatial-temporal resolution of the
intracellular traffic of glucose
Transporter. Klip A: Canadian Institutes
for Health Research, Operating Grant
($663,610 2000-2005)
The Canadian/European trial of
nicotinamide to prevent insulin
dependent diabetes mellitus.
Wherrett D: Medical Research Council of
Canada ($36,000 1998 - 2002).
The genetics and
neuroendocrinology of short
stature. Hamilton J: Lilly International
Growth Study (GeNeSIS) ($50,000 2001 -
2002).
Thyroid hormone and infant visual
development. Rovet J: Canadian
Institutes of Health Research ($328,000
2001 – 2005)
TrialNet - Preservation of beta cells
by glutamate decarboxylase. Wherrett
DK, Mahon J, Daneman D: National Institute
of Health ($1,187,072 2001 - 2008).
Type 1 Diabetes TrialNet - The
Impact of GAD on Preservation of β
Cell Function. Wherrett DK, Mahon J,
Daneman D: National Institutes of Health
($1,960,000 2001-2008)
21